Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Export ethics

This article was originally published in The Gray Sheet

Executive Summary

Regulatory Affairs Professional Society draft code of ethics could address Sec. 802(f) of the FDA Export Reform & Enhancement Act, governing export of certain unapproved products, Hogan & Hartson attorney Linda Horton opines at RAPS Asia Global Awareness conference in Universal City, Calif. June 24. Although a RAPS code is still under development, the former FDAer described Sec. 802(f) as a potential quandary for ethicists, since I don't think FDA has ever invoked" the provision...
Advertisement

Related Content

Reg Affairs Ethics Code To Be Unveiled At October RAPS Annual Meeting
Advertisement
UsernamePublicRestriction

Register

MT018618

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel